Disposition of tradable shares by Seana Carson of Bausch Health at 7.61 subject to Rule 16b-3

BHC Stock  USD 7.34  0.34  4.43%   
About 53% of Bausch Health's investor base is interested to short. The analysis of overall sentiment of trading Bausch Health Companies stock suggests that many investors are impartial at this time. The current market sentiment, together with Bausch Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Bausch Health Companies stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Bausch Health Companies Officer Evp, General Counsel. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 43 common shares, no par value at 7.61 of Bausch Health by Seana Carson on 7th of June 2024. This event was filed by Bausch Health Companies with SEC on 2023-11-06. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Bausch Health's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Bausch Health's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Bausch Health Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Bausch Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bausch Health Fundamental Analysis

We analyze Bausch Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Bausch Health is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Bausch Health Companies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bausch Health stock to make a market-neutral strategy. Peer analysis of Bausch Health could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics with similar companies.

Peers

Bausch Health Related Equities

TEVATeva Pharma   28.41   
0%
100.0%
CTLTCatalent   0.65   
0%
2.0%
NBIXNeurocrine Biosciences   0.91   
3.0%
0%
SHPHShuttle Pharmaceuticals   1.48   
5.0%
0%
TAKTakeda Pharmaceutical   1.87   
6.0%
0%
HLNHaleon Plc   2.02   
7.0%
0%
ZTSZoetis   2.21   
7.0%
0%
VTRSViatris   2.62   
9.0%
0%
TLRYTilray   6.45   
22.0%
0%
LFCRLifecore Biomedical   7.10   
24.0%
0%
EBSEmergent Biosolutions   8.00   
28.0%
0%

Complementary Tools for Bausch Stock analysis

When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios